Medical Management of Endometriosis
Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endomet...
Gespeichert in:
Veröffentlicht in: | Clinical obstetrics and gynecology 2017-09, Vol.60 (3), p.485-496 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 496 |
---|---|
container_issue | 3 |
container_start_page | 485 |
container_title | Clinical obstetrics and gynecology |
container_volume | 60 |
creator | RAFIQUE, SAIMA DECHERNEY, ALAN H |
description | Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology. |
doi_str_mv | 10.1097/GRF.0000000000000292 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5794019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1907002741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</originalsourceid><addsrcrecordid>eNp9kE9LAzEQxYMotv75BiIFL162Jtmk2VwEKW0VWgTRc8gms-3q7qYmW4vf3khrqR6cy8DMm_eGH0IXBPcJluJm8jTu4_2ikh6gLuEpTTin-BB141AmkmLSQSchvGJMGBfkGHVoxiVOCe6iqxnY0uiqN9ONnkMNTdtzRW_UWFdD60sXynCGjgpdBTjf9lP0Mh49D--T6ePkYXg3TQynMVRkudWWQs75AOeUEpsDL2heCJ1aSEVqpM20EcxkhbWDwmqwjFFmhaEEBEtP0e3Gd7nKa7Am_uJ1pZa-rLX_VE6X6vemKRdq7j4UF5JhIqPB9dbAu_cVhFbVZTBQVboBtwqKSCwiJ8FIlLKN1HgXgodiF0Ow-uarIl_1l288u9x_cXf0AzQKso1g7aoWfHirVmvwagG6ahf_e38Bt_WHlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1907002741</pqid></control><display><type>article</type><title>Medical Management of Endometriosis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>RAFIQUE, SAIMA ; DECHERNEY, ALAN H</creator><creatorcontrib>RAFIQUE, SAIMA ; DECHERNEY, ALAN H</creatorcontrib><description>Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.</description><identifier>ISSN: 0009-9201</identifier><identifier>EISSN: 1532-5520</identifier><identifier>DOI: 10.1097/GRF.0000000000000292</identifier><identifier>PMID: 28590310</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Angiogenesis Inhibitors - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Combined Modality Therapy ; Dysmenorrhea - etiology ; Endometriosis - complications ; Endometriosis - drug therapy ; Endometriosis - surgery ; Endometrium - drug effects ; Endometrium - surgery ; Female ; Gonadotropin-Releasing Hormone - therapeutic use ; Hormones - therapeutic use ; Humans ; Pain Management ; Pelvic Pain - etiology ; Treatment Outcome</subject><ispartof>Clinical obstetrics and gynecology, 2017-09, Vol.60 (3), p.485-496</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</citedby><cites>FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28590310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RAFIQUE, SAIMA</creatorcontrib><creatorcontrib>DECHERNEY, ALAN H</creatorcontrib><title>Medical Management of Endometriosis</title><title>Clinical obstetrics and gynecology</title><addtitle>Clin Obstet Gynecol</addtitle><description>Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.</description><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Dysmenorrhea - etiology</subject><subject>Endometriosis - complications</subject><subject>Endometriosis - drug therapy</subject><subject>Endometriosis - surgery</subject><subject>Endometrium - drug effects</subject><subject>Endometrium - surgery</subject><subject>Female</subject><subject>Gonadotropin-Releasing Hormone - therapeutic use</subject><subject>Hormones - therapeutic use</subject><subject>Humans</subject><subject>Pain Management</subject><subject>Pelvic Pain - etiology</subject><subject>Treatment Outcome</subject><issn>0009-9201</issn><issn>1532-5520</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LAzEQxYMotv75BiIFL162Jtmk2VwEKW0VWgTRc8gms-3q7qYmW4vf3khrqR6cy8DMm_eGH0IXBPcJluJm8jTu4_2ikh6gLuEpTTin-BB141AmkmLSQSchvGJMGBfkGHVoxiVOCe6iqxnY0uiqN9ONnkMNTdtzRW_UWFdD60sXynCGjgpdBTjf9lP0Mh49D--T6ePkYXg3TQynMVRkudWWQs75AOeUEpsDL2heCJ1aSEVqpM20EcxkhbWDwmqwjFFmhaEEBEtP0e3Gd7nKa7Am_uJ1pZa-rLX_VE6X6vemKRdq7j4UF5JhIqPB9dbAu_cVhFbVZTBQVboBtwqKSCwiJ8FIlLKN1HgXgodiF0Ow-uarIl_1l288u9x_cXf0AzQKso1g7aoWfHirVmvwagG6ahf_e38Bt_WHlg</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>RAFIQUE, SAIMA</creator><creator>DECHERNEY, ALAN H</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201709</creationdate><title>Medical Management of Endometriosis</title><author>RAFIQUE, SAIMA ; DECHERNEY, ALAN H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Dysmenorrhea - etiology</topic><topic>Endometriosis - complications</topic><topic>Endometriosis - drug therapy</topic><topic>Endometriosis - surgery</topic><topic>Endometrium - drug effects</topic><topic>Endometrium - surgery</topic><topic>Female</topic><topic>Gonadotropin-Releasing Hormone - therapeutic use</topic><topic>Hormones - therapeutic use</topic><topic>Humans</topic><topic>Pain Management</topic><topic>Pelvic Pain - etiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RAFIQUE, SAIMA</creatorcontrib><creatorcontrib>DECHERNEY, ALAN H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RAFIQUE, SAIMA</au><au>DECHERNEY, ALAN H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical Management of Endometriosis</atitle><jtitle>Clinical obstetrics and gynecology</jtitle><addtitle>Clin Obstet Gynecol</addtitle><date>2017-09</date><risdate>2017</risdate><volume>60</volume><issue>3</issue><spage>485</spage><epage>496</epage><pages>485-496</pages><issn>0009-9201</issn><eissn>1532-5520</eissn><abstract>Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28590310</pmid><doi>10.1097/GRF.0000000000000292</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-9201 |
ispartof | Clinical obstetrics and gynecology, 2017-09, Vol.60 (3), p.485-496 |
issn | 0009-9201 1532-5520 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5794019 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Angiogenesis Inhibitors - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Combined Modality Therapy Dysmenorrhea - etiology Endometriosis - complications Endometriosis - drug therapy Endometriosis - surgery Endometrium - drug effects Endometrium - surgery Female Gonadotropin-Releasing Hormone - therapeutic use Hormones - therapeutic use Humans Pain Management Pelvic Pain - etiology Treatment Outcome |
title | Medical Management of Endometriosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20Management%20of%20Endometriosis&rft.jtitle=Clinical%20obstetrics%20and%20gynecology&rft.au=RAFIQUE,%20SAIMA&rft.date=2017-09&rft.volume=60&rft.issue=3&rft.spage=485&rft.epage=496&rft.pages=485-496&rft.issn=0009-9201&rft.eissn=1532-5520&rft_id=info:doi/10.1097/GRF.0000000000000292&rft_dat=%3Cproquest_pubme%3E1907002741%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1907002741&rft_id=info:pmid/28590310&rfr_iscdi=true |